Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes

Necrosis Factor Alpha ◽

Dipeptidyl Peptidase 4 ◽

Factor Alpha ◽

Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases

Parasite Immunology ◽

10.1111/pim.12305 ◽

2016 ◽

Vol 38 (4) ◽

pp. 255-260 ◽

Cited By ~ 10

Author(s):

M. Nateghi Rostami ◽

E. Seyyedan Jasbi ◽

A. Khamesipour ◽

A. M. Mohammadi

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Receptor Type ◽

Soluble Receptor ◽

Necrosis Factor Alpha ◽

Tnf Α ◽

Factor Alpha ◽

Urinary interleukin-6 and tumour necrosis factor-alpha as early markers for diabetic nephropathy in children and adolescents with type 1 diabetes

Sri Lanka Journal of Child Health ◽

10.4038/sljch.v49i3.9146 ◽

2020 ◽

Vol 49 (3) ◽

pp. 269

Author(s):

Mona A Hana ◽

Sahar A Sharaf ◽

Mohamed M Ismail ◽

Marwa F Mira ◽

Marwa Taha ◽

...

Keyword(s):

Type 1 Diabetes ◽

Diabetic Nephropathy ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Early Markers ◽

Factor Alpha ◽

Effect of Erythromycin on Insulin Resistance and Tumour Necrosis Factor-Alpha Levels in Fructose Fed Insulin Resistant Rats

Mansoura Journal of Forensic Medicine and Clinical Toxicology ◽

10.21608/mjfmct.2005.65810 ◽

2005 ◽

Vol 13 (1) ◽

pp. 15-27

Author(s):

Amany Sfwlaby

Keyword(s):

Insulin Resistance ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Insulin Resistant ◽

Factor Alpha ◽

Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)

Human Immunology ◽

10.1016/j.humimm.2012.10.002 ◽

2013 ◽

Vol 74 (1) ◽

pp. 75-81 ◽

Cited By ~ 9

Author(s):

Katarzyna Zorena ◽

Marta Kula ◽

Ewa Malinowska ◽

Dorota Raczyńska ◽

Małgorzata Myśliwiec ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Tumour Necrosis ◽

Serum Concentrations ◽

Necrosis Factor Alpha ◽

Potential Marker ◽

Factor Alpha ◽

Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors

Journal of Internal Medicine ◽

10.1046/j.1365-2796.2000.00705.x ◽

2000 ◽

Vol 248 (1) ◽

pp. 67-76 ◽

Cited By ~ 92

Author(s):

M. Lechleitner ◽

T. Koch ◽

M. Herold ◽

A. Dzien ◽

F. Hoppichler

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 1 Diabetes ◽

Cardiovascular Risk ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer

British Journal of Surgery ◽

10.1002/bjs.1800791240 ◽

1992 ◽

Vol 79 (12) ◽

pp. 1361-1363 ◽

Cited By ~ 49

Author(s):

J. L. McCall ◽

J. A. Tuckey ◽

B. R. Parry

Keyword(s):

Insulin Resistance ◽

Tumour Necrosis Factor ◽

Gastrointestinal Cancer ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumour

Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2441 ◽

2013 ◽

Vol 29 (8) ◽

pp. 655-663 ◽

Cited By ~ 16

Author(s):

Signe Tellerup Nielsen ◽

Louise Lehrskov-Schmidt ◽

Rikke Krogh-Madsen ◽

Thomas P. J. Solomon ◽

Lars Lehrskov-Schmidt ◽

...

Keyword(s):

Insulin Resistance ◽

Healthy Volunteers ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Incretin Effect ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Short-term histopathological response to anti-tumour necrosis factor alpha therapy in patients with ulcerative colitis

10.26226/morressier.596dfd59d462b80292387586 ◽

2017 ◽

Author(s):

Diana-Alexandra Costache

Keyword(s):

Ulcerative Colitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Short Term ◽

Histopathological Response ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response

Faculty Opinions recommendation of Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162910.623534 ◽

2009 ◽

Author(s):

Ulf Müller-Ladner

Keyword(s):

Tumour Necrosis Factor ◽

Dose Escalation ◽

Inflammatory Arthritis ◽

Tumour Necrosis ◽

Phase 1 ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Antagonist ◽